Nexletol is FDA-approved in adults to (1) reduce the risk of major cardiovascular events such as cardiovascular death, heart attack, stroke, or coronary revascularization in people at increased risk who are unable to take recommended statin therapy, and (2) lower LDL cholesterol in primary hyperlipidemia, including heterozygous familial hypercholesterolemia, as an adjunct to diet, alone or with other LDL-lowering drugs when needed.

Off-label, clinicians may use bempedoic acid in statin-intolerant adults who need additional LDL lowering but do not fit exactly into labeled risk categories, or in very high-risk familial hypercholesterolemia (including rare homozygous cases), based on smaller studies and real-world experience; these uses rely on emerging evidence and are not formal FDA indications.

When Nexletol is added to background therapy, LDL cholesterol typically falls by about 15–25% within 4–12 weeks, with most of the effect seen by around 4 weeks; in fixed combination with ezetimibe, average LDL reductions of roughly 35–40% have been observed, and cholesterol levels are usually rechecked 8–12 weeks after starting.

In a large outcomes trial of statin-intolerant patients with or at high risk for cardiovascular disease, bempedoic acid produced about a 21% greater LDL reduction than placebo at 6 months and lowered major cardiovascular events by about 13% relative (roughly 1–2% absolute) over about 3–4 years, mainly by reducing heart attacks and coronary procedures; its LDL-lowering and event-reduction effects are generally smaller than those of high-intensity statins or PCSK9 inhibitors but provide an important oral non-statin option for patients who cannot use or tolerate statins.

For adults, the standard Nexletol dose is 180 mg taken by mouth once daily, at about the same time each day, with or without food; no adjustment is needed for mild to moderate kidney or liver impairment, but the drug has been studied less in severe kidney disease, end-stage renal disease, or severe hepatic impairment, so extra caution is used in those settings.

Swallow the tablet whole with water and continue a heart-healthy diet and any other prescribed cholesterol-lowering medicines unless your clinician changes your regimen; fasting lipid levels are typically checked 8–12 weeks after starting or changing therapy, and if you also take simvastatin or pravastatin, their doses are usually limited (not more than 20 mg of simvastatin or 40 mg of pravastatin daily) to reduce the risk of statin-related muscle problems.

If you miss a dose, take it as soon as you remember unless it is almost time for your next dose, in which case skip the missed dose and resume your usual schedule without taking two doses at once; if too many tablets are taken, contact your healthcare provider, a poison control center, or emergency services immediately.

Common side effects (occurring in a few to several percent of patients) include upper respiratory or flu-like symptoms, muscle spasms, back or limb pain, stomach or abdominal discomfort, bronchitis, increases in uric acid, mild anemia, small rises in liver enzymes, and in heart-disease trials some cases of kidney function changes, gout, and gallstones; these effects usually appear within the first weeks to months and are often mild to moderate.

Serious but less frequent problems needing prompt medical attention include severe allergic reactions (such as swelling of the face, lips, tongue, or throat, difficulty breathing, or widespread rash), marked increases in uric acid or sudden painful, red, swollen joints suggesting gout, signs of tendon injury or rupture (a snap or pop, bruising, swelling, or severe pain in the shoulder, arm, or Achilles area with trouble using the limb), and significant liver injury signs such as dark urine, yellowing of the skin or eyes, or severe fatigue.

Use Nexletol cautiously in people with a history of gout, tendon disorders, kidney disease, or liver disease; uric acid, kidney function, and liver enzymes may be checked, especially if symptoms arise, and the drug should generally be avoided during pregnancy or breastfeeding because it may harm a developing baby and affects cholesterol synthesis in infants; Nexletol is approved only for adults, as safety and effectiveness in children have not been established.

Compared with statins, Nexletol does not act directly in skeletal muscle and has low rates of muscle symptoms in trials, but it carries higher risks of elevated uric acid, gout, and tendon problems than placebo; patients and clinicians should watch for these issues, and suspected side effects can be reported through the FDA MedWatch program or to the manufacturer as described in the prescribing information.

Nexletol can increase blood levels of certain statins, so doses above 20 mg of simvastatin or 40 mg of pravastatin are generally avoided, and your clinician should review all prescription and over-the-counter medicines, vitamins, and herbal supplements you use to look for added risks of muscle problems, kidney effects, or increased uric acid.

There are no specific food restrictions and the medicine may be taken with or without meals, but limiting alcohol helps reduce liver stress, and extra caution is advised when Nexletol is combined with drugs that can affect tendons (such as systemic corticosteroids or fluoroquinolone antibiotics) or increase uric acid, because these combinations may raise the risk of gout or tendon injury.

People with a history of gout, tendon disorders, severe kidney or liver disease, or prior serious reactions to bempedoic acid require particular caution and may not be suitable candidates; monitoring typically includes periodic lipid panels and, when indicated, blood tests for uric acid, kidney function, and liver enzymes, along with clinical checks for new muscle, joint, or tendon symptoms.

Nexletol does not have known significant effects on common imaging or diagnostic tests, but you should always inform healthcare providers that you are taking it before surgery or new treatments so they can adjust other medicines and monitoring as needed.

Q: What is Nexletol used for?
A: Nexletol is prescribed for adults to lower LDL (“bad”) cholesterol in primary hyperlipidemia, including heterozygous familial hypercholesterolemia, and to reduce the risk of major cardiovascular events such as heart attack, stroke, cardiovascular death, or certain heart procedures in people at increased risk who cannot take recommended statin therapy.

Q: How long does it take Nexletol to start working?
A: LDL cholesterol usually begins to fall within the first few weeks of treatment and reaches most of its effect by about 4 weeks, with cholesterol levels often checked again 8–12 weeks after starting the medicine.

Q: Can I take Nexletol with a statin?
A: Many people take Nexletol together with a statin or other cholesterol-lowering drugs, but doses of simvastatin and pravastatin may need to be limited, so your clinician should review your full medication list and adjust other therapies as needed.

Q: Does Nexletol cause muscle pain like statins?
A: Bempedoic acid is activated mainly in the liver rather than in muscle and has low rates of muscle symptoms in studies, but any new or worsening muscle, joint, or tendon pain or weakness should be reported promptly so your clinician can evaluate it.

Q: Is Nexletol safe during pregnancy or while breastfeeding?
A: Nexletol is generally avoided in pregnancy and breastfeeding because it can affect cholesterol synthesis and may harm a developing baby or nursing infant, so people who are pregnant, planning pregnancy, or breastfeeding should discuss alternative options with their clinician.

Q: What should I do if I forget a dose of Nexletol?
A: If you miss a dose, take it as soon as you remember unless it is almost time for your next dose, in which case skip the missed dose and return to your regular schedule without taking two doses at once.

Store Nexletol tablets in the original bottle at room temperature (68°F to 77°F / 20°C to 25°C), with the bottle tightly closed, the drying packet (desiccant) left inside, and the medicine kept away from moisture, excess heat, and light, and out of reach of children and pets.

Do not flush unused tablets; when the medicine is expired or no longer needed, use a medicine take-back program if available, or, if advised by your pharmacist, mix tablets with an undesirable substance (such as used coffee grounds or cat litter), seal in a bag or container, and place in the household trash.